Study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes.

Abortion pills offered via telehealth as safe as in-person medication abortions, study finds

With the Supreme Court just a month away from hearing arguments over access to the abortion medication mifepristone, a new study published on Wednesday in

February 15, 2024

Understanding metabolic alterations and immune dysfunction in acute-on-chronic liver failure

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function in patients with pre-existing chronic liver disease.

November 8, 2024

Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials

Biomea’s BMF-219 is an investigational irreversible covalent inhibitor of menin. Image credit: eamesBot / Shutterstock. Biomea Fusion’s stock is on the up after the company

September 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.